ArticleAmerican journal of preventive cardiology2021

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States.

Seth J Baum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.